Literature DB >> 6132163

Escherichia coli O157:H7 associated with human infections in the United Kingdom.

N P Day, S M Scotland, T Cheasty, B Rowe.   

Abstract

Entities:  

Mesh:

Year:  1983        PMID: 6132163     DOI: 10.1016/s0140-6736(83)91887-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Haemorrhagic colitis and Escherichia coli O157--a pathogen unmasked.

Authors:  J Symonds
Journal:  Br Med J (Clin Res Ed)       Date:  1988-03-26

2.  Properties of strains of Escherichia coli belonging to serogroup O157 with special reference to production of Vero cytotoxins VT1 and VT2.

Authors:  S M Scotland; G A Willshaw; H R Smith; B Rowe
Journal:  Epidemiol Infect       Date:  1987-12       Impact factor: 2.451

3.  Haemolytic uraemic syndromes in the British Isles 1985-8: association with verocytotoxin producing Escherichia coli. Part 1: Clinical and epidemiological aspects.

Authors:  D V Milford; C M Taylor; B Guttridge; S M Hall; B Rowe; H Kleanthous
Journal:  Arch Dis Child       Date:  1990-07       Impact factor: 3.791

Review 4.  Diarrheagenic Escherichia coli.

Authors:  J P Nataro; J B Kaper
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

5.  Sporadic occurrence of hemorrhagic colitis associated with Escherichia coli O157:H7 in Newfoundland.

Authors:  S Ratnam; S B March
Journal:  CMAJ       Date:  1986-01-01       Impact factor: 8.262

6.  Serogroups of Escherichia coli from drinking water.

Authors:  P W Ramteke; Suman Tewari
Journal:  Environ Monit Assess       Date:  2006-10-21       Impact factor: 3.307

7.  Shiga Toxin-Producing Escherichia coli O157, England and Wales, 1983-2012.

Authors:  Natalie L Adams; Lisa Byrne; Geraldine A Smith; Richard Elson; John P Harris; Roland Salmon; Robert Smith; Sarah J O'Brien; Goutam K Adak; Claire Jenkins
Journal:  Emerg Infect Dis       Date:  2016-04       Impact factor: 6.883

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.